Scientists crack structure of a novel enzyme linked to cell growth and cancer

Pinterest LinkedIn Tumblr +

RNA, or ribonucleic acid, is present in the cells of all living beings and required to synthesise proteins.

A research team at the University of California, Riverside, has discovered the structure of a novel RNA-modifying enzyme, ZCCHC4, and identified the mechanism that controls how this enzyme recognises its substrate.

ZCCHC4 influences cell proliferation and has been linked to cancers.

It uniquely introduces one kind of RNA modification, N6-methyladenosine (m6A), into ribosomes, which are cell organelles made up of RNA molecules and protein.

The study, published in Nature Communications, explains how protein machineries in cells are regulated to target RNA molecules for m6A modification.

Jikui Song, an associate professor of biochemistry at UC Riverside who led the study, explained ZCCHC4 controls protein synthesis and cell proliferation by introducing an m6A modification into ribosomes.

ZCCHC4, he added, is over expressed in tumours associated with hepatocellular carcinoma – the most common type of primary liver cancer.

“This is the first time anyone has determined the crystal structure of ZCCHC4,” Song said. “Our discovery can be used for structure-based drug design against cancers and lead to a better understanding of how m6A, a modification associated with numerous biological processes, is installed on ribosomal RNA.”

The m6A modification has received enormous attention in recent years due to the important role it plays in RNA metabolism and biology.

How this modification is dynamically programmed and distributed in cells, however, remains poorly understood.

“The structure of ZCCHC4 provides an understanding of how this enzyme is wired to specifically act on ’28S ribosomal RNA,” Song said, noting a ribosome is assembled with differently sized subunits.

28S ribosomal RNA refers to the RNA component in the 28S ribosomal subunit.

“We now understand that this enzyme is controlled by an ‘auto-inhibitory’ mechanism that has been observed in many other cellular processes,” added Song.

To crack the structure of ZCCHC4, Song’s team first produced an enzymatically active and structurally rigid ZCCHC4 fragment.

The researchers then coaxed this protein to crystallise.

Finally, they diffracted the crystals using X-rays and analysed the data, which led to the eventual discovery of ZCCHC4’s structure.

Last year, Song’s lab solved the crystal structure for an enzyme that plays a key role in DNA methylation, the process by which methyl groups are added to the DNA molecule.

Next, the research team will continue to explore how various DNA and RNA modifications in cells are created, which has strong implications in health and diseases.

Source: University of California – Riverside


About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Leave A Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.